医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.

广告
第一作者: Aditya,Juloori
第一单位: Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois. Electronic address: ajuloori@radonc.uchicago.edu.
作者单位: Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois. Electronic address: ajuloori@radonc.uchicago.edu. [1] Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois. [2] Radiation Oncology Associates, Dover, New Hampshire. [3] Department of Radiation Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York. [4] Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York. [5] Department of Radiation Oncology, University of Arizona Health Sciences Center, Tucson, Arizona. [6] Froedert Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin. [7] Department of Surgery, University of Chicago Medicine, Chicago, Illinois. [8] Department of Medicine, University of Chicago Medicine, Chicago, Illinois. [9] START Midwest, Grand Rapids, Michigan. [10]
DOI 10.1016/j.ijrobp.2022.09.052
PMID 36108891
发布时间 2023-09-13
提交
  • 浏览1
International journal of radiation oncology, biology, physics

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷